EP2478902A1 — Pharmaceutical composition for reducing weight and method for the production thereof
Assigned to Representaciones e Investigaciones Medicas SA de CV · Expires 2012-07-25 · 14y expired
What this patent protects
A pharmaceutical composition is described for reducing weight, which comprises a mixture of Orlistat and L-carnitine, as active ingredients and a pharmaceutically acceptable vehicle. Also described is a method for producing said composition, in which the Orlistat undergoes moiste…
USPTO Abstract
A pharmaceutical composition is described for reducing weight, which comprises a mixture of Orlistat and L-carnitine, as active ingredients and a pharmaceutically acceptable vehicle. Also described is a method for producing said composition, in which the Orlistat undergoes moistening and moist granulation, which offsets problems of sticking or poor fluidity in the case or this compound.
Drugs covered by this patent
- Lamictal (lamotrigine) · GSK
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.